NKTR
Nektar Therapeutics
NASDAQ · Pharmaceuticals
$36.81
+1.69 (+4.81%)
Open$35.18
Previous Close$35.12
Day High$37.26
Day Low$34.47
52W High$66.92
52W Low$6.48
Volume—
Avg Volume619.1K
Market Cap748.77M
P/E Ratio—
EPS$-7.58
SectorPharmaceuticals
Analyst Ratings
Strong Buy
14 analysts
Price Target
+14.7% upside
Current
$36.81
$36.81
Target
$42.23
$42.23
$31.85
$42.23 avg
$63.47
Key Financials
| FY 2026 | FY 2025 | FY 2025 | |
|---|---|---|---|
| Revenue | 146.03M | 147.73M | 233.30M |
| Net Income | -176,493,789 | -160,692,372 | 47.46M |
| Profit Margin | -120.9% | -114.8% | 20.3% |
| EBITDA | -150,139,228 | -144,291,620 | 100.43M |
| Free Cash Flow | — | — | 58.83M |
| Rev Growth | -1.2% | -1.2% | +12.6% |
| Debt/Equity | — | — | 0.99 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,058.18 | +3.66% | 48.5 | 1.00T |
| JNJ | Johnson & Johnson | $239.99 | +0.93% | 21.6 | 578.21B |
| MRK | Merck & Co. Inc. | $121.93 | +1.82% | 16.6 | 302.63B |
| PFE | Pfizer Inc. | $27.22 | +2.76% | 19.9 | 154.76B |
| BMY | Bristol-Myers Squibb Co | $61.99 | +4.15% | 17.9 | 126.20B |
| ZTS | Zoetis Inc | $127.42 | +0.54% | 21.5 | 56.95B |